✦ LIBER ✦

189 REGISTRATION OF DIGITAL HISTOLOGY IMAGES TO IN VIVO MRI FOR PROSTATE CANCER FOCAL THERAPY RESEARCH

✍ Scribed by Ward, Aaron; Crukley, Cathie; McKenzie, Charles; Montreuil, Jacques; Gibson, Eli; Romagnoli, Cesare; Gomez, Jose; Moussa, Madeleine; Chin, Joseph; Bauman, Glenn; Fenster, Aaron

Book ID: 123480047
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 323 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[IEEE 2011 8th IEEE International Sympos

[IEEE 2011 8th IEEE International Symposium on Biomedical Imaging (ISBI 2011) - Chicago, IL, USA (2011.03.30-2011.04.2)] 2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro - Tissue block MRI for slice orientation-independent registration of digital histology images to ex vivo MRI of the prostate

✍ Gibson, Eli; Crukley, Cathie; Gomez, Jose A.; Moussa, Madeleine; Bauman, Glenn; 📂 Article 📅 2011 🏛 IEEE ⚖ 514 KB

[IEEE 2011 33rd Annual International Con

[IEEE 2011 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society - Boston, MA (2011.08.30-2011.09.3)] 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society - Spatially weighted mutual information (SWMI) for registration of digitally reconstructed ex vivo whole mount histology and in vivo prostate MRI

✍ Patel, P.; Chappelow, J.; Tomaszewski, J.; Feldman, M. D.; Rosen, M.; Shih, N.; 📂 Article 📅 2011 🏛 IEEE 🌐 English ⚖ 616 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB